Treatment as Prevention¨

HIV Aids Cure News 2017: New Study Pays People $10 to Be Tested and Treated for the Disease

A new Canadian study is paying people $10 each to be tested or treated for HIV/AIDS. The British Columbia Centre for Excellence in HIV/AIDS researchers behind this effort initiated the study on Friday, beginning with 139 people from Prince George, Victoria, Surrey, and Vancouver. The participants were chosen for health issues that make them at […]

HIV Aids Cure News 2017: New Study Pays People $10 to Be Tested and Treated for the Disease Read More »

City endorses international TasP-awareness campaign

Chicago Department of Public Health announced on Sept. 28 that city officials were joining the international “U=U” promotional campaign aimed both at raising awareness about the effectiveness of HIV treatment and reducing stigmatization of persons with HIV/AIDS. “U=U” is an abbreviation for “Undetectable=Untransmittable.” The campaign was launched in 2016 by the Prevention Access Campaign, an

City endorses international TasP-awareness campaign Read More »

Australian clinic records show significant reduction in duration of infectiousness in HIV-positive gay men from 2007-2016

The period during which HIV-positive men who have sex with men (MSM) are potentially infectious fell significantly between 2007 and 2016, investigators from Australia report in the online edition of AIDS. Data from Melbourne Sexual Health Centre showed that the intervals between HIV infection and diagnosis, between diagnosis to viral suppression and between infection to

Australian clinic records show significant reduction in duration of infectiousness in HIV-positive gay men from 2007-2016 Read More »

B.C. assesses Truvada, an HIV prevention drug that looks ‘very promising’

Health experts in B.C. are examining an HIV prevention drug that a Vancouver gay men’s health group wants to see covered provincially. The drug, called Truvada, was approved by Health Canada last year, and is prescribed both as a treatment for people with the disease, and as a preventative therapy meant to keep the virus

B.C. assesses Truvada, an HIV prevention drug that looks ‘very promising’ Read More »

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025